Other OTC - Delayed Quote USD

Medinotec Inc. (MDNC)

5.0000 0.0000 (0.00%)
At close: July 14 at 10:33 AM EDT
Key Events
Advanced Chart
Loading Chart for MDNC
DELL
  • Previous Close 5.0000
  • Open 5.0000
  • Bid --
  • Ask --
  • Day's Range 5.0000 - 5.0000
  • 52 Week Range 5.0000 - 5.0000
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 58.669M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medinotec Inc. engages in the research and development, production, and sale of medical devices. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. It serves customers in South Africa and internationally. The company was incorporated in 2021 and is based in Johannesburg, South Africa.

www.medinotecinc.com

29

Full Time Employees

February 28

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about Medinotec Inc.

Recent News: MDNC

View More
View More

Performance Overview: MDNC

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MDNC
0.00%
S&P 500
6.92%

1-Year Return

MDNC
--
S&P 500
13.20%

3-Year Return

MDNC
--
S&P 500
13.20%

5-Year Return

MDNC
--
S&P 500
13.20%

Compare To: MDNC

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

MDNC
Medinotec Inc.
5.0000
0.00%
Mkt Cap 58.669M
Industry Medical Devices
BVS
Bioventus Inc.
3.9800
-2.21%
Mkt Cap 252.248M
Industry Medical Devices

Statistics: MDNC

View More

Valuation Measures

Annual
As of 4/27/2024

  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    19.01

  • Enterprise Value/EBITDA

    -303.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.59%

  • Return on Assets (ttm)

    4.38%

  • Return on Equity (ttm)

    -24.33%

  • Revenue (ttm)

    3.05M

  • Net Income Avi to Common (ttm)

    -566.91k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.68M

  • Total Debt/Equity (mrq)

    76.16%

  • Levered Free Cash Flow (ttm)

    455.18k

View More

Company Insights: MDNC